RPH3A emerges as a promising target for reversing synaptic loss in Parkinson's disease
Aug. 24, 2022
Parkinson's disease (PD) is the second most common neurodegenerative disorder and is characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the abnormal accumulation and aggregation of alpha-synuclein.